机译:对早期结直肠癌癌症新有前途非编码RNA诊断生物标志物的试验研究
Cancer Hospital and Institute of Guangzhou Medical University Guangzhou P.R. China;
CAS Key Laboratory of Tissue Microenvironment and Tumor Shanghai Institute of Nutrition and Health;
General Surgery Department Ruijin Hospital Shanghai Jiao Tong University School of Medicine;
General Surgery Department Ruijin Hospital Shanghai Jiao Tong University School of Medicine;
General Surgery Department Ruijin Hospital Shanghai Jiao Tong University School of Medicine;
CAS Key Laboratory of Tissue Microenvironment and Tumor Shanghai Institute of Nutrition and Health;
General Surgery Department Ruijin Hospital Shanghai Jiao Tong University School of Medicine;
Cancer Hospital and Institute of Guangzhou Medical University Guangzhou P.R. China;
biomarker; colorectal cancer; LncRNA; plasma;
机译:对早期结直肠癌癌症新有前途非编码RNA诊断生物标志物的试验研究
机译:长非编码RNA:用于癌症诊断的新型新兴生物标志物
机译:环状RNA hsa_circ_0000567可用作人类大肠癌的有前途的诊断生物标志物
机译:循环无细胞的DNA基QMSP证明了Sydecan2甲基化作为有望的表观遗传生物标志物,用于早期检测患癌前和癌细胞病患者的患者
机译:炎症,2型糖尿病和癌症:鉴定与结肠直肠癌和2型糖尿病相关的生物标志物,以及使用MicroRNA分子作为癌症治疗的治疗用途
机译:长期非编码RNA H19UCA1和HOTAIR对人类膀胱癌有希望的生物标志物的诊断价值
机译:>血清PiRNA签名是对结直肠癌的非侵入性诊断和预后生物标志物的血清piRNA签名 p>
机译:开发用于检测早期肺癌DNa甲基化生物标志物的诊断工具。